Results 151 to 160 of about 42,265 (195)

Two distinct degenerative types of nigrostriatal dopaminergic neuron in the early stage of parkinsonian disorders. [PDF]

Clin Park Relat Disord
Kawazoe T, Sugaya K, Nakata Y, Okitsu M, Takahashi K.   +4 more
europepmc   +1 more source

Magnetic Resonance Imaging and Nuclear Imaging of Parkinsonian Disorders: Where do we go from here? [PDF]

Curr Neuropharmacol
Savoie FA, Arpin DJ, Vaillancourt DE.
europepmc   +1 more source

Intrastriatal gradient analyses of 18F-FDOPA PET scans for differentiation of Parkinsonian disorders. [PDF]

Neuroimage Clin, 2020
Stormezand GN, Chaves LT, Vállez García D, Doorduin J, De Jong BM, Leenders KL, Kremer BPH, Dierckx RAJO.   +7 more
europepmc   +1 more source

A New Statistical Framework for Corpus Callosum Sub-Region Characterization Based on LBP Texture in Patients With Parkinsonian Disorders: A Pilot Study. [PDF]

Front Neurosci, 2020
Bhattacharya D, Sinha N, Prasad S, Pal PK, Saini J, Mangalore S.   +5 more
europepmc   +1 more source

Analysis of biomarkers in speculative CNS-enriched extracellular vesicles for parkinsonian disorders: a comprehensive systematic review and diagnostic meta-analysis. [PDF]

J Neurol
Taha HB, Bogoniewski A.
europepmc   +1 more source

Erratum: A General Neurologist's Practical Diagnostic Algorithm for Atypical Parkinsonian Disorders: A Consensus Statement. [PDF]

Neurol Clin Pract
europepmc   +1 more source

Brain monoamine oxidases in human parkinsonian disorders [PDF]

Brain, 2017
openaire   +2 more sources

Sensor-based gait analysis in atypical parkinsonian disorders. [PDF]

Brain Behav, 2018
Raccagni C, Gaßner H, Eschlboeck S, Boesch S, Krismer F, Seppi K, Poewe W, Eskofier BM, Winkler J, Wenning G, Klucken J.   +10 more
europepmc   +1 more source